Abstract:Background: Precise gene dosage of the X chromosomes is critical for normal development and cellular function. In mice, XX female somatic cells show transcriptional X chromosome upregulation of their single active X chromosome, while the other X chromosome is inactive. Moreover, the inactive X chromosome is reactivated during development in the inner cell mass and in germ cells through X chromosome reactivation, which can be studied in vitro by reprogramming of somatic cells to pluripotency. How chromatin processes and gene regulatory networks evolved to regulate X chromosome dosage in the somatic state and during X chromosome reactivation remains unclear. Results: Using genome-wide approaches, allele-specific ATAC-seq and single-cell RNA-seq, in female embryonic fibroblasts and during reprogramming to pluripotency, we show that chromatin accessibility on the upregulated mammalian active X chromosome is increased compared to autosomes. We further show that increased accessibility on the active X chromosome is erased by reprogramming, accompanied by erasure of transcriptional X chromosome upregulation and the loss of increased transcriptional burst frequency. In addition, we characterize gene regulatory networks during reprogramming and X chromosome reactivation, revealing changes in regulatory states. Our data show that ZFP42/REX1, a pluripotency-associated gene that evolved specifically in placental mammals, targets multiple X-linked genes, suggesting an evolutionary link between ZFP42/REX1, X chromosome reactivation, and pluripotency. Conclusions: Our data reveal the existence of intrinsic compensatory mechanisms that involve modulation of chromatin accessibility to counteract X-to-Autosome gene dosage imbalances caused by evolutionary or in vitro X chromosome loss and X chromosome inactivation in mammalian cells.

Erosion of Human X Chromosome Inactivation Causes Major Remodeling of the Ipsc Proteome

Erosion of X-Chromosome Inactivation in female hiPSCs is heterogeneous and persists during differentiation

De-erosion of X chromosome dosage compensation by the editing of XIST regulatory regions restores the differentiation potential in hPSCs

X-chromosome inactivation in human iPSCs provides insight into X-regulated gene expression in autosomes

Enhancement of Xrcc1-mediated Base Excision Repair Improves the Genetic Stability and Pluripotency of Ipscs

X-inactivation in Female Human Embryonic Stem Cells is in a Nonrandom Pattern and Prone to Epigenetic Alterations

Dynamic Erasure of Random X-Chromosome Inactivation during iPSC Reprogramming

Deletion of the XIST promoter from the human inactive X chromosome compromises polycomb heterochromatin maintenance

Cohesin controls X chromosome structure remodeling and X-reactivation during mouse iPSC-reprogramming

Integrated analysis of Xist upregulation and X-chromosome inactivation with single-cell and single-allele resolution

Characterization of X Chromosome Inactivation Using Integrated Analysis of Whole-Exome and mRNA Sequencing

XIST dampens X chromosome activity in a SPEN-dependent manner during early human development

Modeling X chromosome inactivation using t5iLA naive human pluripotent stem cells

The Dynamic Changes of X Chromosome Inactivation During Early Culture of Human Embryonic Stem Cells

Bioinformatic Analysis of the Molecular Pathways of ATRX and XIST in X Chromosome Inactivation

Xist repression shows time-dependent effects on the reprogramming of female somatic cells to induced pluripotent stem cells.

Dynamic reversal of random X-Chromosome inactivation during iPSC reprogramming

Integrated analysis of Xist upregulation and gene silencing at the onset of random X-chromosome inactivation at high temporal and allelic resolution

Skewed X chromosome inactivation in diploid and triploid female human embryonic stem cells.

Pseudoautosomal Region 1 Overdosage Affects the Global Transcriptome in iPSCs From Patients With Klinefelter Syndrome and High-Grade X Chromosome Aneuploidies

Enhanced chromatin accessibility contributes to X chromosome dosage compensation in mammals